We are live on
!
Find out more
GL
GTCR LLC Portfolio holdings
AUM
$3.91B
1-Year Est. Return
14.64%
This Fund
S&P 500
This Quarter
Est. Return
+15.52%
1 Year Est. Return
+14.64%
3 Year Est. Return
-6.7%
5 Year Est. Return
+17.1%
10 Year Est. Return
–
AUM
$3.94B
AUM Growth
+$353M
(+9.8%)
Cap. Flow
-$143M
Cap. Flow
% of AUM
-3.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Maravai LifeSciences
MRVI
|
+$143M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 73.6% |
| 2 | Communication Services | 13.93% |
| 3 | Industrials | 12.47% |
Similar funds
LNC
AC
DCM
BI
FFGIM
LFCM
LCM
SCM
GTCR LLC's Q3 2021 Portfolio in Review
As of Q3 2021, GTCR LLC held 4 positions worth $3.94B, up 9.8% from $3.59B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
GTCR LLC withdrew a net $143M in Q3 2021, reducing 1 holding. Its largest reduction was Maravai LifeSciences, cutting an estimated $143M.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 76% a quarter earlier, followed by Communication Services and Industrials.
- GTCR LLC's biggest Q3 2021 reduction was Maravai LifeSciences, cutting an estimated $143M.
- GTCR LLC's ten largest holdings make up 100% of its $3.94B portfolio in Q3 2021.
- GTCR LLC opened 0 new positions and closed 0 in Q3 2021.
- GTCR LLC's portfolio value rose 9.8% quarter-over-quarter to $3.94B.
Based on GTCR LLC's 13F filing for Q3 2021, filed 1 Nov 2021.